ArticleBMJ open2023

Efficacy and safety of Android artificial pancreas system use at home among adults with type 1 diabetes mellitus in China: protocol of a 26-week, free-living, randomised, open-label, two-arm, two-phase, crossover trial.

Mengyun Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.